DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

Axplora’s Chasse-sur-Rhône CDMO site in France has successfully passed its latest on-site inspection by the ANSM.

Artificial intelligence (AI) is rapidly transforming the pharmaceutical industry, reshaping the landscape from target identification to personalized ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

There are 33 industrial zones operating at present throughout the island, and out of them, 08 zones are in the Western ...

The Cabinet of Ministers has approved the proposal presented by the President, in his capacity as the Minister of Finance, ...

BioNTech SE and BMS have partnered for the global co-development and co-commercialization of BNT327 across numerous solid ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

Russell U.S. Indexes, provided by FTSE Russell, are widely used by investment managers and institutional investors as benchmarks for active and passive investment strategies. As of May 2025, ...

The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...